These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 8999656
1. [Effect of captopril on angiotensin-converting enzyme activity and animal behavior in the "open field" test]. Vernigora AN, Gengin MT, Nikishin NN, Shchetinina NV. Vopr Med Khim; 1996; 42(1):34-8. PubMed ID: 8999656 [Abstract] [Full Text] [Related]
3. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats. Hu WY, Chen DG, Chen SC, Jin XQ, Wang HJ. Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143 [Abstract] [Full Text] [Related]
5. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. Sacco G, Mario B, Lopez G, Evangelista S, Manzini S, Maggi CA. Vascul Pharmacol; 2009 Nov; 50(5-6):166-70. PubMed ID: 19344651 [Abstract] [Full Text] [Related]
10. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats. Ninahuaman MF, Souccar C, Lapa AJ, Lima-Landman MT. Phytomedicine; 2007 May 28; 14(5):321-7. PubMed ID: 17433647 [Abstract] [Full Text] [Related]
11. [The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme]. Vernigora AN, Nikishin NN, Gengin MT. Biokhimiia; 1995 Jan 28; 60(1):144-9. PubMed ID: 7696431 [Abstract] [Full Text] [Related]
16. Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9 activity in patients with Kawasaki disease. Inoue N, Takai S, Jin D, Okumura K, Okamura N, Kajiura M, Yoshikawa S, Kawamura N, Tamai H, Miyazaki M. Clin Chim Acta; 2010 Feb 28; 411(3-4):267-9. PubMed ID: 19945447 [Abstract] [Full Text] [Related]
17. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR. Haddad G, Garcia R. J Mol Cell Cardiol; 1997 Feb 28; 29(2):813-22. PubMed ID: 9140837 [Abstract] [Full Text] [Related]
18. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme. Grinshtein SV, Binevski PV, Gomazkov OA, Pozdnev VF, Nikolskaya II, Kost OA. Biochemistry (Mosc); 1999 Aug 28; 64(8):938-44. PubMed ID: 10498812 [Abstract] [Full Text] [Related]
19. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Cascieri MA, Bull HG, Mumford RA, Patchett AA, Thornberry NA, Liang T. Mol Pharmacol; 1984 Mar 28; 25(2):287-93. PubMed ID: 6199659 [Abstract] [Full Text] [Related]
20. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis. Windt WA, Prakash J, Kok RJ, Moolenaar F, Kluppel CA, de Zeeuw D, van Dokkum RP, Henning RH. J Renin Angiotensin Aldosterone Syst; 2004 Dec 28; 5(4):197-202. PubMed ID: 15803438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]